Literature DB >> 1427075

An essential splicing factor, SLU7, mediates 3' splice site choice in yeast.

D Frank1, C Guthrie.   

Abstract

Recently, we have reported the identification of several genes that exhibit genetic interactions with the U5 snRNA. Two of these genes, SLU4 and SLU7 (SLU: synergistic lethal with U5 snRNA), encode products required for the second catalytic step of splicing. To analyze the specific roles of SLU4 and SLU7, we have determined how mutants influence the relative usage of competing 3' splice sites. We find that mutations in SLU7 eliminate the normal 20-fold preference for 3' splice sites located > 22 nucleotides downstream of the branchpoint. In contrast, mutations in SLU4 inhibit usage of all 3' splice sites, regardless of their location. This suggests that SLU7 is involved in the process of 3' splice site choice, whereas SLU4 fulfills a generic requirement for the second step. We show that SLU7 is an essential gene that contains a small motif with striking similarity to the cysteine-rich zinc knuckle of retroviral nucleocapsid proteins, which has been implicated in RNA binding. Mutational analysis of SLU7 indicates that this motif influences the efficiency, but not the sequence specificity, of 3' splice site selection. The identification of a component of the constitutive splicing machinery that can promote 3' splice site choice has potentially important implications for alternative splicing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427075     DOI: 10.1101/gad.6.11.2112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  79 in total

1.  An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing.

Authors:  K Chua; R Reed
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Role of the 3' splice site in U12-dependent intron splicing.

Authors:  R C Dietrich; M J Peris; A S Seyboldt; R A Padgett
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

4.  Identification of a U2/U6 helix la mutant that influences 3' splice site selection during nuclear pre-mRNA splicing.

Authors:  J S Chang; D S McPheeters
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

5.  Genetic interactions between the 5' and 3' splice site consensus sequences and U6 snRNA during the second catalytic step of pre-mRNA splicing.

Authors:  C A Collins; C Guthrie
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

6.  Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.

Authors:  Noam Shomron; Hadar Malca; Ida Vig; Gil Ast
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

7.  Large-scale proteomic analysis of the human spliceosome.

Authors:  Juri Rappsilber; Ursula Ryder; Angus I Lamond; Matthias Mann
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

8.  Splicing factor hSlu7 contains a unique functional domain required to retain the protein within the nucleus.

Authors:  Noam Shomron; Mika Reznik; Gil Ast
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

9.  Genetic and functional interaction of evolutionarily conserved regions of the Prp18 protein and the U5 snRNA.

Authors:  Dagmar Bacíková; David S Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  The KH domain of the branchpoint sequence binding protein determines specificity for the pre-mRNA branchpoint sequence.

Authors:  J A Berglund; M L Fleming; M Rosbash
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.